Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation

Shirley McCartney; Chris G. Yedinak; Troy H. Dillard; Kevin S. Wei; Maria Fleseriu

doi:10.12688/f1000research.3062.1

Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation

Shirley McCartney, Chris G. Yedinak, Troy H. Dillard, Kevin S. Wei, Maria Fleseriu

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.

Original language	English (US)
Article number	3062.1
Journal	F1000Research
Volume	3
DOIs	https://doi.org/10.12688/f1000research.3062.1
State	Published - Jul 25 2014

ASJC Scopus subject areas

General Immunology and Microbiology
General Pharmacology, Toxicology and Pharmaceutics
General Biochemistry, Genetics and Molecular Biology

Access to Document

10.12688/f1000research.3062.1

Cite this

@article{db369b65fa09484bb6b3b0310df70433,

title = "Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation",

abstract = "We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.",

author = "Shirley McCartney and Yedinak, {Chris G.} and Dillard, {Troy H.} and Wei, {Kevin S.} and Maria Fleseriu",

note = "Publisher Copyright: {\textcopyright} 2014 Yedinak CG et al.",

year = "2014",

month = jul,

day = "25",

doi = "10.12688/f1000research.3062.1",

language = "English (US)",

volume = "3",

journal = "F1000Research",

issn = "2046-1402",

publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Case Report

T2 - Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation

AU - McCartney, Shirley

AU - Yedinak, Chris G.

AU - Dillard, Troy H.

AU - Wei, Kevin S.

AU - Fleseriu, Maria

PY - 2014/7/25

Y1 - 2014/7/25

N2 - We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.

AB - We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed after discontinuation of cabergoline therapy.

UR - http://www.scopus.com/inward/record.url?scp=84915818648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915818648&partnerID=8YFLogxK

U2 - 10.12688/f1000research.3062.1

DO - 10.12688/f1000research.3062.1

M3 - Article

AN - SCOPUS:84915818648

SN - 2046-1402

VL - 3

JO - F1000Research

JF - F1000Research

M1 - 3062.1

ER -

Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this